Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.58 |
| ▸ | PTGDR2 | Q9Y5Y4 | 6/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL341639 | 0.85 | KDM4E (0.73) | L3MBTL1POLBSMN1; SMN2GLAPTGDR2 | |
| SCHEMBL8414408 | 0.85 | L3MBTL1 (0.61) | L3MBTL1POLBSMN1; SMN2GLAPTGDR2 | |
| SCHEMBL29502958 | 0.85 | KDM4E (0.73) | L3MBTL1POLBSMN1; SMN2GLAPTGDR2 | |
| SCHEMBL637155 | 0.84 | HTT (0.72) | L3MBTL1SMN1; SMN2ALDH1A1KDM4EHTT | |
| SCHEMBL9285384 | 0.82 | PTGDR2 (0.56) | L3MBTL1POLBSMN1; SMN2GLAPTGDR2 | |
| SCHEMBL9331793 | 0.82 | L3MBTL1 (0.59) | L3MBTL1POLBSMN1; SMN2GLAPTGDR2 | |
| SCHEMBL340762 | 0.82 | L3MBTL1 (0.80) | L3MBTL1POLBSMN1; SMN2GLAPTGDR2 | |
| SCHEMBL29682135 | 0.82 | L3MBTL1 (0.80) | L3MBTL1POLBSMN1; SMN2GLAPTGDR2 | |
| SCHEMBL14273085 | 0.81 | L3MBTL1 (0.58) | L3MBTL1POLBSMN1; SMN2GLAPTGDR2 | |
| SCHEMBL24290 | 0.81 | KDM4E (0.64) | L3MBTL1POLBSMN1; SMN2GLAPTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2859356-A2 | PATHWAYS CHARACTERIZATION OF CELLS | Nodality, Inc. (US) | 2015-04-15 | — | — | EP | disclosed |
| WO-2013188469-A2 | PATHWAYS CHARACTERIZATION OF CELLS | NODALITY, INC. (US) | 2013-12-19 | — | — | WO | disclosed |
| WO-2013112948-A1 | BENCHMARKS FOR NORMAL CELL IDENTIFICATION | NODALITY, INC. (US) | 2013-08-01 | — | — | WO | disclosed |
| EP-2539470-A1 | METHODS FOR AUTOIMMUNE DISEASE DIAGNOSIS, PROGNOSIS, AND TREATMENT | The Board of Trustees of The Leland Stanford Junior University (US) | 2013-01-02 | — | — | EP | disclosed |
| WO-2011119868-A2 | HYPER-SPATIAL METHODS FOR MODELING BIOLOGICAL EVENTS | NODALITY, INC. (US) | 2011-09-29 | — | — | WO | disclosed |
| WO-2011106558-A1 | METHODS FOR AUTOIMMUNE DISEASE DIAGNOSIS, PROGNOSIS, AND TREATMENT | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2011-09-01 | — | — | WO | disclosed |
| EP-2304436-A1 | METHODS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT | Nodality, Inc. (US) | 2011-04-06 | — | — | EP | disclosed |
| WO-2010006291-A1 | METHODS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT | NODALITY, INC. (US) | 2010-01-14 | — | — | WO | disclosed |